Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2025-12-26 @ 3:12 AM
Study NCT ID:
NCT06656520
Status:
WITHDRAWN
Last Update Posted:
2024-10-24
First Post:
2024-10-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Impact of Telehealth Care
Sponsor:
Pei-Hung Liao
Organization:
Study Overview
Official Title:
Impact of Telehealth Care on Clinical Outcomes in Heart Failure Patients
Status:
WITHDRAWN
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
A retrospective observational study was conducted using electronic medical record data
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Heart failure is associated with high incidence and mortality rates, limited physical activity, decreased quality of life, and increased healthcare expenses. Implementing a Telehealth Care (TC) HF program could address these challenges while improving patient outcomes.
Detailed Description:
Telemonitoring for heart failure patients reduces all-cause and cardiovascular mortality by enabling early intervention during clinical deterioration, improving outcomes even for those recently discharged. Moreover, a reduction in the percentage of days lost due to unplanned cardiovascular hospital admissions is evident. Furthermore, the rapid expansion of telehealth care and telemedicine services during the COVID-19 pandemic optimized the management and care quality of heart failure patients through telemonitoring .
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: